Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company focused on developing targeted oncology therapies, has announced upcoming presentations at two major investor conferences. CEO and Co-founder Brian Sullivan will participate in:
- A fireside chat at the TD Cowen 6th Annual Oncology Innovation Summit on May 28, 2025, at 9:30 a.m. ET
- A fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, at 7:35 a.m. ET
Both presentations will be available via live webcast and can be accessed through the company's investor relations website, with recordings available shortly after the events.
Celcuity Inc. (NASDAQ: CELC), un'azienda biotecnologica in fase clinica specializzata nello sviluppo di terapie oncologiche mirate, ha annunciato la partecipazione a due importanti conferenze per investitori. Il CEO e cofondatore Brian Sullivan prender脿 parte a:
- Una conversazione informale al TD Cowen 6th Annual Oncology Innovation Summit il 28 maggio 2025 alle 9:30 ET
- Una conversazione informale al Jefferies Global Healthcare Conference il 5 giugno 2025 alle 7:35 ET
Entrambe le presentazioni saranno trasmesse in diretta via webcast e potranno essere seguite attraverso il sito web delle relazioni con gli investitori della societ脿, con le registrazioni disponibili poco dopo gli eventi.
Celcuity Inc. (NASDAQ: CELC), una empresa biotecnol贸gica en etapa cl铆nica enfocada en el desarrollo de terapias oncol贸gicas dirigidas, ha anunciado presentaciones pr贸ximas en dos importantes conferencias para inversionistas. El CEO y cofundador Brian Sullivan participar谩 en:
- Una charla informal en el TD Cowen 6th Annual Oncology Innovation Summit el 28 de mayo de 2025 a las 9:30 a.m. ET
- Una charla informal en el Jefferies Global Healthcare Conference el 5 de junio de 2025 a las 7:35 a.m. ET
Ambas presentaciones estar谩n disponibles v铆a webcast en vivo y se podr谩n acceder a trav茅s del sitio web de relaciones con inversionistas de la compa帽铆a, con grabaciones disponibles poco despu茅s de los eventos.
Celcuity Inc. (NASDAQ: CELC)電� 響滌爜 頃晹 旃橂鞝� 臧滊皽鞐� 欤茧牓頃橂姅 鞛勳儊 雼硠鞚� 靸濍獏瓿淀暀 須岇偓搿�, 霊� 臧滌潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐愳劀 氚滍憸頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. CEO鞚挫瀽 瓿惦彊 彀诫鞛愳澑 敫岆澕鞚挫柛 靹るΜ氚橃澊 彀胳棳頃� 鞓堨爼鞛呺媹雼�:
- 2025雲� 5鞗� 28鞚� 鞓れ爠 9鞁� 30攵�(霃欕秬鞁滉皠) TD Cowen 6th Annual Oncology Innovation Summit鞐愳劀鞚� 韺岇澊鞏挫偓鞚措摐 毂勴寘
- 2025雲� 6鞗� 5鞚� 鞓れ爠 7鞁� 35攵�(霃欕秬鞁滉皠) Jefferies Global Healthcare Conference鞐愳劀鞚� 韺岇澊鞏挫偓鞚措摐 毂勴寘
霊� 氚滍憸 氇憪 霛检澊敫� 鞗轨簮鞀ろ姼搿� 鞝滉车霅橂┌, 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞝戩啀頃� 靾� 鞛堦碃, 頄夓偓 膦呺 歆來泟 雲鬼檾氤鸽弰 鞝滉车霅� 鞓堨爼鞛呺媹雼�.
Celcuity Inc. (NASDAQ : CELC), une soci茅t茅 biotechnologique en phase clinique sp茅cialis茅e dans le d茅veloppement de th茅rapies oncologiques cibl茅es, a annonc茅 ses prochaines interventions lors de deux grandes conf茅rences pour investisseurs. Le PDG et cofondateur Brian Sullivan participera 脿 :
- Un 茅change informel lors du TD Cowen 6th Annual Oncology Innovation Summit le 28 mai 2025 脿 9h30 ET
- Un 茅change informel lors de la Jefferies Global Healthcare Conference le 5 juin 2025 脿 7h35 ET
Les deux pr茅sentations seront diffus茅es en direct par webcast et accessibles via le site des relations investisseurs de la soci茅t茅, avec des enregistrements disponibles peu apr猫s les 茅v茅nements.
Celcuity Inc. (NASDAQ: CELC), ein biotechnologisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung zielgerichteter Krebstherapien spezialisiert hat, hat bevorstehende Pr盲sentationen auf zwei bedeutenden Investorenkonferenzen angek眉ndigt. CEO und Mitgr眉nder Brian Sullivan wird teilnehmen an:
- Einem Fireside Chat beim TD Cowen 6th Annual Oncology Innovation Summit am 28. Mai 2025 um 9:30 Uhr ET
- Einem Fireside Chat auf der Jefferies Global Healthcare Conference am 5. Juni 2025 um 7:35 Uhr ET
Beide Pr盲sentationen werden live per Webcast 眉bertragen und k枚nnen 眉ber die Investor-Relations-Website des Unternehmens abgerufen werden, mit Aufzeichnungen, die kurz nach den Veranstaltungen verf眉gbar sind.
- None.
- None.
MINNEAPOLIS, May 21, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences:
- A fireside chat at the TD Cowen: 6th Annual Oncology Innovation Summit at 9:30 a.m. ET on Wednesday, May 28, 2025. A live webcast will be available using this weblink: ; and
- A fireside chat at the Jefferies Global Healthcare Conference at 7:35 a.m. ET on Thursday, June 5, 2025. A live webcast will be available using this weblink: .
Alternatively, the live webcasts will be accessible from the Investors section of the company's website at with a replay available shortly after the live events.
About Celcuity听
Celcuity is a clinical-stage biotechnology company pursuing development of targeted therapies for treatment of multiple solid tumor indications. The company's lead therapeutic candidate is gedatolisib, a potent, pan-PI3K and mTORC1/2 inhibitor that comprehensively blockades the PI3K/AKT/mTOR (鈥淧AM鈥�) pathway. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K伪, AKT, or mTORC1 alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients. More detailed information about the VIKTORIA-1 study can be found at听. A Phase 1b/2 clinical trial, CELC-G-201, evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is ongoing. A Phase 3 clinical trial, VIKTORIA-2, evaluating gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+/HER2- advanced breast cancer is currently recruiting patients. Celcuity is headquartered in Minneapolis.听Further information about Celcuity can be found at听. Follow us on听听and听.
Contacts:听
Celcuity Inc.听
Brian Sullivan, 听
Vicky Hahne, 听
(763) 392-0123听
ICR Healthcare
Patti Bank,听
(415) 513-1284
FAQ
When is Celcuity (CELC) presenting at the TD Cowen Oncology Innovation Summit?
What time is Celcuity's presentation at the Jefferies Global Healthcare Conference?
Who will be presenting at the upcoming investor conferences for Celcuity (CELC)?
How can investors access Celcuity's conference presentations?
